- Highlights
- Full Text
[1:25] ..." a look at genes that we're defined. In the development of the human genome. "...
[1:36] ..." the function or role of those teams that were discovered in the human genome project. Work so easy -- used in research to figure out what those teens did. It's heart disease. Now RAI is used to try and developed -- that would actually target those genes --"...
[1:55] ..." talking about diseases that up to this time have been a pretty untreatable. "...
[2:23] ..." Now how close is the relationship of your company with the umass in the research done there."...
[2:29] ..." very closeness that that we licensed a lot of our technology from umass medical better. And three of our founders are professors at umass Medical Center."...
[2:40] ..." And you are located quite close to umass Medical Center street. What do you see down -- down the road as we look on the street there looking down the"...
[3:34] ..." and magic one was Luke air disease and technology licensed in from umass medical that are looking at gene that's involved in only one form of Lou Gehrig's disease. And that the genetic four. And"...
[0:01]" It was founded in spot out of not a public company founded by Craig Mello. Who won the Nobel prize for his discovery -- And that the optic networks doing at an architect pharmaceuticals were developed cardiac therapeutic."
[0:17]" Tell me about -- the focus of your company and you're -- it's it's a very exciting field researcher --"
[0:25]" Yes it it. The -- is we are targeting our day which is a different way of doing drug development compared to traditional drug development. Candidate said it was discovered by air founder and our team has worked on these type project targeting -- Arnie for many years. It actually allows you to island. A target -- That -- causes disease."
[0:51]" what does the future look like for this type of technology."
[0:54]" Well the field has really been very exciting field in the last few years there's been one company's debt was acquired by Merck for over a billion dollars last year. And another one of our peers -- in market cap it's gone up to over a billion dollars so there's been a lot of growth in the value in -- and that's because there's been a lot of interest in pharmaceutical companies. In developing RD --"
[1:22]" Now it does does this research also take a look at genes that we're defined. In the development of the human genome. "
[1:29]" That's a good question it it does it does more than that the the -- A was first used Arctic high. To look at what the function or role of those teams that were discovered in the human genome project. Work so easy -- used in research to figure out what those teens did. It's heart disease. Now RAI is used to try and developed -- that would actually target those genes --"
[1:55]" And we're talking about diseases that up to this time have been a pretty untreatable. "
[2:01]" Yes he. It certainly sounds some diseases would be one at a -- been treated in May be Arnie I would you better treatment. But other diseases such as our program looking at KLS or Lou Gehrig's disease. He's using the targeting aren't AI RNA two as a new approach to treating it very difficult that he's."
[2:23]" Now how close is the relationship of your company with the umass in the research done there."
[2:29]" Well it it's very closeness that that we licensed a lot of our technology from umass medical better. And three of our founders are professors at umass Medical Center."
[2:40]" And you are located quite close to umass Medical Center street. What do you see down -- down the road as we look on the street there looking down the road 345 years what does the future hold for the type of research."
[2:57]" Well the the future of this. Research is is that it took its attack it's -- technology that very broad. You can potentially target any disease any -- with this technology. So it's really there's a lot of growth because there are so many genes and diseases there's many different potential applications. So it's -- technology which shall keep hearing more more about as people look exploited and used it in in different ways for different diseases."
[3:28]" And what are some of the first diseases that you are targeting here in your research."
[3:33]" Yes and magic one was Luke air disease and technology licensed in from umass medical that are looking at gene that's involved in only one form of Lou Gehrig's disease. And that the genetic four. And so that's one of our our programs and I must say to listeners that this is is today preclinical stage where in the discovery stage just to search lab tests -- not topic. That is in any -- available right now for for the public another area that we're looking at is in the metabolic disease. So that would include things like cholesterol -- into high cholesterol and obesity and type two diabetes"
Del.icio.us
Digg
Reddit
